These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 15064116
1. Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials. Subbiah MT. Atherosclerosis; 2004 Apr; 173(2):373-4. PubMed ID: 15064116 [No Abstract] [Full Text] [Related]
2. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? Barton M, Meyer MR, Haas E. Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1669-72. PubMed ID: 17634518 [No Abstract] [Full Text] [Related]
3. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001 Aug; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
4. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause. Rosano GM, Mercuro G. G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956 [No Abstract] [Full Text] [Related]
5. Women, hormones, and clinical trials: a beginning, not an end. Miller VM, Clarkson TB, Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Naftolin F, Santoro N. J Appl Physiol (1985); 2005 Aug; 99(2):381-3. PubMed ID: 16020431 [No Abstract] [Full Text] [Related]
6. Comments on Women, hormones, and clinical trials: a beginning, not an end. Minson CT, Kaplan P, Meendering JR, Torgrimson BN, Miller NP. J Appl Physiol (1985); 2006 Jan; 100(1):373. PubMed ID: 16357092 [No Abstract] [Full Text] [Related]
7. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J. Arch Intern Med; 2004 Nov 08; 164(20):2253-9. PubMed ID: 15534163 [Abstract] [Full Text] [Related]
8. New trial to test hormone therapy in younger women. Harv Womens Health Watch; 2005 Nov 08; 13(3):6. PubMed ID: 16408352 [No Abstract] [Full Text] [Related]
9. [Coronary artery disease and menopausal hormone therapy]. Mizia-Stec K, Zahorska-Markiewicz B, Gasior Z, Holecki M. Pol Arch Med Wewn; 2004 Oct 08; 112(4):1255-63. PubMed ID: 15773440 [No Abstract] [Full Text] [Related]
10. Hormone in the hot seat. Mandavilli A. Nat Med; 2006 Jan 08; 12(1):8-9. PubMed ID: 16397539 [No Abstract] [Full Text] [Related]
11. Hormone replacement therapy and coronary artery disease: buried alive? Bahl VK, Naik N. Indian Heart J; 2002 Jan 08; 54(1):23-30. PubMed ID: 11999084 [No Abstract] [Full Text] [Related]
17. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials. Cho L, Mukherjee D. Cardiology; 2005 Apr 22; 104(3):143-7. PubMed ID: 16118493 [Abstract] [Full Text] [Related]
18. Introduction: menopausal hormone therapy: where are we today? Cedars MI. Fertil Steril; 2014 Apr 22; 101(4):885-6. PubMed ID: 24613540 [Abstract] [Full Text] [Related]
19. Benefits and risks of long-term low-dose oral continuous combined hormone therapy. van de Weijer PH, Mattsson LA, Ylikorkala O. Maturitas; 2007 Mar 20; 56(3):231-48. PubMed ID: 17034966 [Abstract] [Full Text] [Related]
20. The new conundrum: do estrogens have any cardiovascular benefits? Clarkson TB. Int J Fertil Womens Med; 2002 Mar 20; 47(2):61-8. PubMed ID: 11991432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]